This past April marked the 10-year anniversary of the release of the first human genome reference sequence, an epic milestone in the annals of medical science. The use of “first-generation sequencing” required over a decade and almost $3 billion. Today’s NGS technologies can do the same in 3 days for a cost of only $3,000. This represents a remarkable leap in efficiency, making NGS viable even for selected clinical applications. But the real growth in clinical sequencing is yet to come.
10 hours ago
6 days ago
Lexogen has developed the first commercial Covid-19 ultra-high-throughput test for true public health mass screening
18 days ago
October 15, 2020
Ceres Nanosciences receives SBIR grant to adapt its virus capture technology to portable RNA sequencing tools for improved SARS-CoV-2 surveillance
September 30, 2020